By Kelly Cloonan
ISpecimen said it would raise about $5.5 million in gross proceeds in a private placement.
Under the agreement, iSpecimen will issue 6,875 shares of new Series C Convertible Preferred Stock at $800 apiece, the online marketplace for healthcare specimens said Tuesday.
Each share of the preferred stock is convertible into shares of the company's common stock at a price of 85% of the last closing price of the common stock.
The company intends to use the proceeds from the offering for marketing, working capital and general corporate purposes.
The offering is expected to close around Dec. 31.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
December 30, 2025 14:48 ET (19:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments